Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Home Use Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Home Use Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-10-23
Pages: 190 Pages
Report ld: 5207315
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Home Use Lancets Market Size(US$)
CAGR 2025-2031
4.5%
Market Size,2031
USD 1,611
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,237 million
Market Forecast in 2031(Value)
US$ 1,611 million
CAGR
4.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Home Use Lancets market is projected to grow from US$ 1189 million in 2024 to US$ 1611 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Home use lancets are small, sharp devices specifically designed for personal use at home to obtain a blood sample for various health tests, such as blood glucose monitoring. These lancets are often used with a lancing device that controls the depth of the puncture to minimize discomfort. Home use lancets are typically disposable, sterile, and easy to handle, allowing individuals to manage their health conveniently and safely in a non-clinical setting.
Market Drivers:
Rising prevalence of diabetes: The increasing number of people diagnosed with diabetes globally has driven demand for home-based blood glucose monitoring systems, including lancets. With diabetes requiring regular blood sugar checks, home use lancets are a vital tool for self-monitoring.
Shift toward home healthcare: The growing preference for home-based healthcare, driven by convenience and the need to reduce healthcare costs, has fueled the demand for home use lancets. Patients can now easily monitor their health without frequent clinic visits, further increasing the adoption of these devices.
Technological advancements: Innovations in lancet design, such as ultra-thin needles and automated lancing devices that reduce pain, have improved the user experience. This has led to greater acceptance of home use lancets, especially among individuals concerned about discomfort during testing.
Increased awareness of preventive care: As people become more health-conscious, there is a growing emphasis on regular health monitoring, even for individuals without diagnosed medical conditions. This trend is boosting the adoption of home use lancets for routine blood tests.
Aging population: The global aging population, which is more prone to chronic diseases such as diabetes, is a significant factor driving the demand for home use lancets. Older adults require frequent health monitoring, making home testing devices an essential part of their daily healthcare routines.
Challenges:
Competition from non-invasive technologies: The development of non-invasive glucose monitoring systems and other diagnostic tools that don't require finger pricks presents a major challenge to the home use lancets market. These alternatives reduce the need for lancets, potentially limiting market growth.
Cost concerns: While lancets are relatively affordable, they are disposable and need frequent replenishment, which can become a recurring cost burden for users, especially those in low-income regions. This financial aspect can limit widespread adoption.
User discomfort and fear of needles: Despite advances in reducing pain, some individuals still avoid regular testing due to needle anxiety or discomfort associated with finger pricks. This can limit the consistent use of home use lancets, particularly among younger or more sensitive users.
Environmental impact: Since lancets are disposable, they contribute to medical waste. As environmental concerns rise, this could affect consumer behavior or lead to increased regulatory pressure on manufacturers to develop more sustainable or reusable solutions.
Regulatory and safety issues: Lancets used at home must adhere to strict safety and quality standards to prevent contamination or infection. Meeting these regulatory requirements can be a challenge for manufacturers, potentially delaying product innovation or increasing costs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Home Use Lancets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Roche
- Lifescan
- BD
- Ascensia
- Abbott
- B. Braun
- ARKRAY
- Terumo
- I-SENS
- Nipro
- Cardinal Health
- ICU Medical
- Sarstedt
- Sinocare
- Yicheng
- Yuwell
- Greiner Bio One
- Guangzhou iCare Medical
- Shandong Lianfa
- Tianjin Huahong
- Owen Mumford
- HemoCue
- HTL-STREFA
- UltiMed
- SteriLance Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Safety Lancets
- Ordinary Lancets
Segment by Application
- Cholesterol Tests
- Glucose Tests
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Home Use Lancets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Home Use Lancets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Home Use Lancets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Safety Lancets
1.2.3 Ordinary Lancets
1.3 Market Segmentation by Application
1.3.1 Global Home Use Lancets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cholesterol Tests
1.3.3 Glucose Tests
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Home Use Lancets Revenue Estimates and Forecasts 2020-2031
2.2 Global Home Use Lancets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Home Use Lancets Sales Estimates and Forecasts 2020-2031
2.4 Global Home Use Lancets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Home Use Lancets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Home Use Lancets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Safety Lancets Market Size by Manufacturers
3.5.2 Ordinary Lancets Market Size by Manufacturers
3.6 Global Home Use Lancets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Home Use Lancets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Home Use Lancets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Home Use Lancets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Home Use Lancets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Home Use Lancets Sales and Revenue by Type (2020-2031)
6.4 North America Home Use Lancets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Home Use Lancets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Home Use Lancets Sales and Revenue by Type (2020-2031)
7.4 Europe Home Use Lancets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Home Use Lancets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Home Use Lancets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Home Use Lancets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Home Use Lancets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Home Use Lancets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Home Use Lancets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Home Use Lancets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Home Use Lancets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Home Use Lancets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Home Use Lancets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Business Overview
11.1.3 Roche Home Use Lancets Product Models, Descriptions and Specifications
11.1.4 Roche Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Roche Home Use Lancets Sales by Product in 2024
11.1.6 Roche Home Use Lancets Sales by Application in 2024
11.1.7 Roche Home Use Lancets Sales by Geographic Area in 2024
11.1.8 Roche Home Use Lancets SWOT Analysis
11.1.9 Roche Recent Developments
11.2 Lifescan
11.2.1 Lifescan Corporation Information
11.2.2 Lifescan Business Overview
11.2.3 Lifescan Home Use Lancets Product Models, Descriptions and Specifications
11.2.4 Lifescan Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Lifescan Home Use Lancets Sales by Product in 2024
11.2.6 Lifescan Home Use Lancets Sales by Application in 2024
11.2.7 Lifescan Home Use Lancets Sales by Geographic Area in 2024
11.2.8 Lifescan Home Use Lancets SWOT Analysis
11.2.9 Lifescan Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Business Overview
11.3.3 BD Home Use Lancets Product Models, Descriptions and Specifications
11.3.4 BD Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 BD Home Use Lancets Sales by Product in 2024
11.3.6 BD Home Use Lancets Sales by Application in 2024
11.3.7 BD Home Use Lancets Sales by Geographic Area in 2024
11.3.8 BD Home Use Lancets SWOT Analysis
11.3.9 BD Recent Developments
11.4 Ascensia
11.4.1 Ascensia Corporation Information
11.4.2 Ascensia Business Overview
11.4.3 Ascensia Home Use Lancets Product Models, Descriptions and Specifications
11.4.4 Ascensia Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Ascensia Home Use Lancets Sales by Product in 2024
11.4.6 Ascensia Home Use Lancets Sales by Application in 2024
11.4.7 Ascensia Home Use Lancets Sales by Geographic Area in 2024
11.4.8 Ascensia Home Use Lancets SWOT Analysis
11.4.9 Ascensia Recent Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Business Overview
11.5.3 Abbott Home Use Lancets Product Models, Descriptions and Specifications
11.5.4 Abbott Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Abbott Home Use Lancets Sales by Product in 2024
11.5.6 Abbott Home Use Lancets Sales by Application in 2024
11.5.7 Abbott Home Use Lancets Sales by Geographic Area in 2024
11.5.8 Abbott Home Use Lancets SWOT Analysis
11.5.9 Abbott Recent Developments
11.6 B. Braun
11.6.1 B. Braun Corporation Information
11.6.2 B. Braun Business Overview
11.6.3 B. Braun Home Use Lancets Product Models, Descriptions and Specifications
11.6.4 B. Braun Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 B. Braun Recent Developments
11.7 ARKRAY
11.7.1 ARKRAY Corporation Information
11.7.2 ARKRAY Business Overview
11.7.3 ARKRAY Home Use Lancets Product Models, Descriptions and Specifications
11.7.4 ARKRAY Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 ARKRAY Recent Developments
11.8 Terumo
11.8.1 Terumo Corporation Information
11.8.2 Terumo Business Overview
11.8.3 Terumo Home Use Lancets Product Models, Descriptions and Specifications
11.8.4 Terumo Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Terumo Recent Developments
11.9 I-SENS
11.9.1 I-SENS Corporation Information
11.9.2 I-SENS Business Overview
11.9.3 I-SENS Home Use Lancets Product Models, Descriptions and Specifications
11.9.4 I-SENS Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 I-SENS Recent Developments
11.10 Nipro
11.10.1 Nipro Corporation Information
11.10.2 Nipro Business Overview
11.10.3 Nipro Home Use Lancets Product Models, Descriptions and Specifications
11.10.4 Nipro Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Nipro Recent Developments
11.11 Cardinal Health
11.11.1 Cardinal Health Corporation Information
11.11.2 Cardinal Health Business Overview
11.11.3 Cardinal Health Home Use Lancets Product Models, Descriptions and Specifications
11.11.4 Cardinal Health Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Cardinal Health Recent Developments
11.12 ICU Medical
11.12.1 ICU Medical Corporation Information
11.12.2 ICU Medical Business Overview
11.12.3 ICU Medical Home Use Lancets Product Models, Descriptions and Specifications
11.12.4 ICU Medical Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 ICU Medical Recent Developments
11.13 Sarstedt
11.13.1 Sarstedt Corporation Information
11.13.2 Sarstedt Business Overview
11.13.3 Sarstedt Home Use Lancets Product Models, Descriptions and Specifications
11.13.4 Sarstedt Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Sarstedt Recent Developments
11.14 Sinocare
11.14.1 Sinocare Corporation Information
11.14.2 Sinocare Business Overview
11.14.3 Sinocare Home Use Lancets Product Models, Descriptions and Specifications
11.14.4 Sinocare Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Sinocare Recent Developments
11.15 Yicheng
11.15.1 Yicheng Corporation Information
11.15.2 Yicheng Business Overview
11.15.3 Yicheng Home Use Lancets Product Models, Descriptions and Specifications
11.15.4 Yicheng Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Yicheng Recent Developments
11.16 Yuwell
11.16.1 Yuwell Corporation Information
11.16.2 Yuwell Business Overview
11.16.3 Yuwell Home Use Lancets Product Models, Descriptions and Specifications
11.16.4 Yuwell Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Yuwell Recent Developments
11.17 Greiner Bio One
11.17.1 Greiner Bio One Corporation Information
11.17.2 Greiner Bio One Business Overview
11.17.3 Greiner Bio One Home Use Lancets Product Models, Descriptions and Specifications
11.17.4 Greiner Bio One Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Greiner Bio One Recent Developments
11.18 Guangzhou iCare Medical
11.18.1 Guangzhou iCare Medical Corporation Information
11.18.2 Guangzhou iCare Medical Business Overview
11.18.3 Guangzhou iCare Medical Home Use Lancets Product Models, Descriptions and Specifications
11.18.4 Guangzhou iCare Medical Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Guangzhou iCare Medical Recent Developments
11.19 Shandong Lianfa
11.19.1 Shandong Lianfa Corporation Information
11.19.2 Shandong Lianfa Business Overview
11.19.3 Shandong Lianfa Home Use Lancets Product Models, Descriptions and Specifications
11.19.4 Shandong Lianfa Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Shandong Lianfa Recent Developments
11.20 Tianjin Huahong
11.20.1 Tianjin Huahong Corporation Information
11.20.2 Tianjin Huahong Business Overview
11.20.3 Tianjin Huahong Home Use Lancets Product Models, Descriptions and Specifications
11.20.4 Tianjin Huahong Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Tianjin Huahong Recent Developments
11.21 Owen Mumford
11.21.1 Owen Mumford Corporation Information
11.21.2 Owen Mumford Business Overview
11.21.3 Owen Mumford Home Use Lancets Product Models, Descriptions and Specifications
11.21.4 Owen Mumford Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Owen Mumford Recent Developments
11.22 HemoCue
11.22.1 HemoCue Corporation Information
11.22.2 HemoCue Business Overview
11.22.3 HemoCue Home Use Lancets Product Models, Descriptions and Specifications
11.22.4 HemoCue Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 HemoCue Recent Developments
11.23 HTL-STREFA
11.23.1 HTL-STREFA Corporation Information
11.23.2 HTL-STREFA Business Overview
11.23.3 HTL-STREFA Home Use Lancets Product Models, Descriptions and Specifications
11.23.4 HTL-STREFA Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 HTL-STREFA Recent Developments
11.24 UltiMed
11.24.1 UltiMed Corporation Information
11.24.2 UltiMed Business Overview
11.24.3 UltiMed Home Use Lancets Product Models, Descriptions and Specifications
11.24.4 UltiMed Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.24.5 UltiMed Recent Developments
11.25 SteriLance Medical
11.25.1 SteriLance Medical Corporation Information
11.25.2 SteriLance Medical Business Overview
11.25.3 SteriLance Medical Home Use Lancets Product Models, Descriptions and Specifications
11.25.4 SteriLance Medical Home Use Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
11.25.5 SteriLance Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Home Use Lancets Industry Chain
12.2 Home Use Lancets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Home Use Lancets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Home Use Lancets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Home Use Lancets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Home Use Lancets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Home Use Lancets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Home Use Lancets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Home Use Lancets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Home Use Lancets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Home Use Lancets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Home Use Lancets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Home Use Lancets Sales by Region (2020-2025) & (K Units)
Table 8. Global Home Use Lancets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Home Use Lancets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Home Use Lancets Sales Share by Manufacturers (2020-2025)
Table 12. Global Home Use Lancets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Home Use Lancets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Home Use Lancets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Home Use Lancets as of 2024)
Table 16. Global Home Use Lancets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Home Use Lancets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Home Use Lancets Manufacturing Base and Headquarters
Table 19. Global Home Use Lancets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Home Use Lancets Sales by Type (2020-2025) & (K Units)
Table 23. Global Home Use Lancets Sales by Type (2026-2031) & (K Units)
Table 24. Global Home Use Lancets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Home Use Lancets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Home Use Lancets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Home Use Lancets Sales by Application (2020-2025) & (K Units)
Table 29. Global Home Use Lancets Sales by Application (2026-2031) & (K Units)
Table 30. Home Use Lancets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Home Use Lancets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Home Use Lancets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Home Use Lancets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Home Use Lancets Growth Accelerators and Market Barriers
Table 37. North America Home Use Lancets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Home Use Lancets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Home Use Lancets Growth Accelerators and Market Barriers
Table 40. Europe Home Use Lancets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Home Use Lancets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Home Use Lancets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Home Use Lancets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Home Use Lancets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Home Use Lancets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Home Use Lancets Investment Opportunities and Key Challenges
Table 47. Central and South America Home Use Lancets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Home Use Lancets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Home Use Lancets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Roche Corporation Information
Table 51. Roche Description and Major Businesses
Table 52. Roche Product Models, Descriptions and Specifications
Table 53. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Roche Sales Value Proportion by Product in 2024
Table 55. Roche Sales Value Proportion by Application in 2024
Table 56. Roche Sales Value Proportion by Geographic Area in 2024
Table 57. Roche Home Use Lancets SWOT Analysis
Table 58. Roche Recent Developments
Table 59. Lifescan Corporation Information
Table 60. Lifescan Description and Major Businesses
Table 61. Lifescan Product Models, Descriptions and Specifications
Table 62. Lifescan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Lifescan Sales Value Proportion by Product in 2024
Table 64. Lifescan Sales Value Proportion by Application in 2024
Table 65. Lifescan Sales Value Proportion by Geographic Area in 2024
Table 66. Lifescan Home Use Lancets SWOT Analysis
Table 67. Lifescan Recent Developments
Table 68. BD Corporation Information
Table 69. BD Description and Major Businesses
Table 70. BD Product Models, Descriptions and Specifications
Table 71. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. BD Sales Value Proportion by Product in 2024
Table 73. BD Sales Value Proportion by Application in 2024
Table 74. BD Sales Value Proportion by Geographic Area in 2024
Table 75. BD Home Use Lancets SWOT Analysis
Table 76. BD Recent Developments
Table 77. Ascensia Corporation Information
Table 78. Ascensia Description and Major Businesses
Table 79. Ascensia Product Models, Descriptions and Specifications
Table 80. Ascensia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Ascensia Sales Value Proportion by Product in 2024
Table 82. Ascensia Sales Value Proportion by Application in 2024
Table 83. Ascensia Sales Value Proportion by Geographic Area in 2024
Table 84. Ascensia Home Use Lancets SWOT Analysis
Table 85. Ascensia Recent Developments
Table 86. Abbott Corporation Information
Table 87. Abbott Description and Major Businesses
Table 88. Abbott Product Models, Descriptions and Specifications
Table 89. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Abbott Sales Value Proportion by Product in 2024
Table 91. Abbott Sales Value Proportion by Application in 2024
Table 92. Abbott Sales Value Proportion by Geographic Area in 2024
Table 93. Abbott Home Use Lancets SWOT Analysis
Table 94. Abbott Recent Developments
Table 95. B. Braun Corporation Information
Table 96. B. Braun Description and Major Businesses
Table 97. B. Braun Product Models, Descriptions and Specifications
Table 98. B. Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. B. Braun Recent Developments
Table 100. ARKRAY Corporation Information
Table 101. ARKRAY Description and Major Businesses
Table 102. ARKRAY Product Models, Descriptions and Specifications
Table 103. ARKRAY Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. ARKRAY Recent Developments
Table 105. Terumo Corporation Information
Table 106. Terumo Description and Major Businesses
Table 107. Terumo Product Models, Descriptions and Specifications
Table 108. Terumo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Terumo Recent Developments
Table 110. I-SENS Corporation Information
Table 111. I-SENS Description and Major Businesses
Table 112. I-SENS Product Models, Descriptions and Specifications
Table 113. I-SENS Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. I-SENS Recent Developments
Table 115. Nipro Corporation Information
Table 116. Nipro Description and Major Businesses
Table 117. Nipro Product Models, Descriptions and Specifications
Table 118. Nipro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Nipro Recent Developments
Table 120. Cardinal Health Corporation Information
Table 121. Cardinal Health Description and Major Businesses
Table 122. Cardinal Health Product Models, Descriptions and Specifications
Table 123. Cardinal Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Cardinal Health Recent Developments
Table 125. ICU Medical Corporation Information
Table 126. ICU Medical Description and Major Businesses
Table 127. ICU Medical Product Models, Descriptions and Specifications
Table 128. ICU Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. ICU Medical Recent Developments
Table 130. Sarstedt Corporation Information
Table 131. Sarstedt Description and Major Businesses
Table 132. Sarstedt Product Models, Descriptions and Specifications
Table 133. Sarstedt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Sarstedt Recent Developments
Table 135. Sinocare Corporation Information
Table 136. Sinocare Description and Major Businesses
Table 137. Sinocare Product Models, Descriptions and Specifications
Table 138. Sinocare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Sinocare Recent Developments
Table 140. Yicheng Corporation Information
Table 141. Yicheng Description and Major Businesses
Table 142. Yicheng Product Models, Descriptions and Specifications
Table 143. Yicheng Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Yicheng Recent Developments
Table 145. Yuwell Corporation Information
Table 146. Yuwell Description and Major Businesses
Table 147. Yuwell Product Models, Descriptions and Specifications
Table 148. Yuwell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Yuwell Recent Developments
Table 150. Greiner Bio One Corporation Information
Table 151. Greiner Bio One Description and Major Businesses
Table 152. Greiner Bio One Product Models, Descriptions and Specifications
Table 153. Greiner Bio One Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Greiner Bio One Recent Developments
Table 155. Guangzhou iCare Medical Corporation Information
Table 156. Guangzhou iCare Medical Description and Major Businesses
Table 157. Guangzhou iCare Medical Product Models, Descriptions and Specifications
Table 158. Guangzhou iCare Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Guangzhou iCare Medical Recent Developments
Table 160. Shandong Lianfa Corporation Information
Table 161. Shandong Lianfa Description and Major Businesses
Table 162. Shandong Lianfa Product Models, Descriptions and Specifications
Table 163. Shandong Lianfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Shandong Lianfa Recent Developments
Table 165. Tianjin Huahong Corporation Information
Table 166. Tianjin Huahong Description and Major Businesses
Table 167. Tianjin Huahong Product Models, Descriptions and Specifications
Table 168. Tianjin Huahong Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Tianjin Huahong Recent Developments
Table 170. Owen Mumford Corporation Information
Table 171. Owen Mumford Description and Major Businesses
Table 172. Owen Mumford Product Models, Descriptions and Specifications
Table 173. Owen Mumford Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Owen Mumford Recent Developments
Table 175. HemoCue Corporation Information
Table 176. HemoCue Description and Major Businesses
Table 177. HemoCue Product Models, Descriptions and Specifications
Table 178. HemoCue Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. HemoCue Recent Developments
Table 180. HTL-STREFA Corporation Information
Table 181. HTL-STREFA Description and Major Businesses
Table 182. HTL-STREFA Product Models, Descriptions and Specifications
Table 183. HTL-STREFA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 184. HTL-STREFA Recent Developments
Table 185. UltiMed Corporation Information
Table 186. UltiMed Description and Major Businesses
Table 187. UltiMed Product Models, Descriptions and Specifications
Table 188. UltiMed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 189. UltiMed Recent Developments
Table 190. SteriLance Medical Corporation Information
Table 191. SteriLance Medical Description and Major Businesses
Table 192. SteriLance Medical Product Models, Descriptions and Specifications
Table 193. SteriLance Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 194. SteriLance Medical Recent Developments
Table 195. Key Raw Materials Distribution
Table 196. Raw Materials Key Suppliers
Table 197. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 198. Milestones in Production Technology Evolution
Table 199. Distributors List
Table 200. Market Trends and Market Evolution
Table 201. Market Drivers and Opportunities
Table 202. Market Challenges, Risks, and Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Home Use Lancets Product Picture
Figure 2. Global Home Use Lancets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Safety Lancets Product Picture
Figure 4. Ordinary Lancets Product Picture
Figure 5. Global Home Use Lancets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Cholesterol Tests
Figure 7. Glucose Tests
Figure 8. Others
Figure 9. Home Use Lancets Report Years Considered
Figure 10. Global Home Use Lancets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 12. Global Home Use Lancets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Home Use Lancets Revenue Market Share by Region (2020-2031)
Figure 14. Global Home Use Lancets Sales (2020-2031) & (K Units)
Figure 15. Global Home Use Lancets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Home Use Lancets Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Home Use Lancets Sales Volume Market Share in 2024
Figure 18. Global Home Use Lancets Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Safety Lancets Revenue Market Share by Manufacturer in 2024
Figure 21. Ordinary Lancets Revenue Market Share by Manufacturer in 2024
Figure 22. Global Home Use Lancets Sales Market Share by Type (2020-2031)
Figure 23. Global Home Use Lancets Revenue Market Share by Type (2020-2031)
Figure 24. Global Home Use Lancets Sales Market Share by Application (2020-2031)
Figure 25. Global Home Use Lancets Revenue Market Share by Application (2020-2031)
Figure 26. North America Home Use Lancets Sales YoY (2020-2031) & (K Units)
Figure 27. North America Home Use Lancets Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Home Use Lancets Sales Revenue (US$ Million) in 2024
Figure 29. North America Home Use Lancets Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Home Use Lancets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Home Use Lancets Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Home Use Lancets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Home Use Lancets Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Home Use Lancets Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Home Use Lancets Sales Revenue (US$ Million) in 2024
Figure 39. Europe Home Use Lancets Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Home Use Lancets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Home Use Lancets Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Home Use Lancets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 44. France Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Home Use Lancets Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Home Use Lancets Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Home Use Lancets Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Home Use Lancets Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Home Use Lancets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Home Use Lancets Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Home Use Lancets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 59. India Home Use Lancets Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Home Use Lancets Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Home Use Lancets Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Home Use Lancets Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Home Use Lancets Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Home Use Lancets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Home Use Lancets Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Home Use Lancets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Home Use Lancets Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Home Use Lancets Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Home Use Lancets Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Home Use Lancets Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Home Use Lancets Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Home Use Lancets Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Home Use Lancets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Home Use Lancets Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Home Use Lancets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Home Use Lancets Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Home Use Lancets Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Home Use Lancets Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Home Use Lancets Revenue (2020-2025) & (US$ Million)
Figure 80. Home Use Lancets Industry Chain Mapping
Figure 81. Regional Home Use Lancets Manufacturing Base Distribution (%)
Figure 82. Global Home Use Lancets Production Market Share by Region (2020-2031)
Figure 83. Home Use Lancets Production Process
Figure 84. Regional Home Use Lancets Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 4.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Home Use Lancets in 2025?
What was the global market size of Home Use Lancets in 2031?
What is the annual compound growth rate of the global Home Use Lancets market size from 2025 to 2031?
Which companies rank high in the global Home Use Lancets market?
Related Reports
Global Home Use Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Home Use Lancets market is projected to grow from US$ 1237 million in 2025 to US$ 1676 million by 2032, at a CAGR of 4.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 189
USD 4900.00
(Single User License)
Global Home Use Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Home Use Lancets market size was US$ 1237 million in 2025 and is forecast to reach a readjusted size of US$ 1676 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 116
USD 4250.00
(Single User License)
Home Use Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Home Use Lancets was estimated to be worth US$ 1237 million in 2025 and is projected to reach US$ 1676 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 167
USD 3950.00
(Single User License)
Global Home Use Lancets Market Research Report 2026
The global Home Use Lancets market was valued at US$ 1237 million in 2025 and is anticipated to reach US$ 1676 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 146
USD 2900.00
(Single User License)
Home Use Lancets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Home Use Lancets was estimated to be worth US$ 1189 million in 2024 and is forecast to a readjusted size of US$ 1611 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 154
USD 3950.00
(Single User License)
Global Home Use Lancets Market Insights, Forecast to 2031
The global Home Use Lancets market is projected to grow from US$ 1237 million in 2025 to US$ 1611 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
Published Date: 2025-04-13
Pages: 199
USD 4900.00
(Single User License)
Global Home Use Lancets Market Research Report 2025
The global market for Home Use Lancets was valued at US$ 1189 million in the year 2024 and is projected to reach a revised size of US$ 1611 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published Date: 2025-04-13
Pages: 114
USD 2900.00
(Single User License)
Global Home Use Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Home Use Lancets market size was US$ 1189 million in 2024 and is forecast to a readjusted size of US$ 1611 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 119
USD 4250.00
(Single User License)
Home Use Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Home Use Lancets was estimated to be worth US$ 1189 million in 2024 and is forecast to a readjusted size of US$ 1611 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-02-19
Pages: 167
USD 3950.00
(Single User License)
Global and Japan Home Use Lancets Market Report & Forecast 2024-2030
Home use lancets are small, sharp devices specifically designed for personal use at home to obtain a blood sample for various health tests, such as blood glucose monitoring. These lancets are often used with a lancing device that controls the depth of the puncture to minimize discomfort. Home use lancets are typically disposable, sterile, and easy to handle, allowing individuals to manage their health conveniently and safely in a non-clinical setting.
Published Date: 2024-10-23
Pages: 171
USD 4350.00
(Single User License)
Global Home Use Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Home Use Lancets market is projected to grow from US$ 1237 million in 2025 to US$ 1676 million by 2032, at a CAGR of 4.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 189
USD 4900.00 (Single User License)Global Home Use Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Home Use Lancets market size was US$ 1237 million in 2025 and is forecast to reach a readjusted size of US$ 1676 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 116
USD 4250.00 (Single User License)Home Use Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Home Use Lancets was estimated to be worth US$ 1237 million in 2025 and is projected to reach US$ 1676 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 167
USD 3950.00 (Single User License)Global Home Use Lancets Market Research Report 2026
The global Home Use Lancets market was valued at US$ 1237 million in 2025 and is anticipated to reach US$ 1676 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 146
USD 2900.00 (Single User License)Home Use Lancets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Home Use Lancets was estimated to be worth US$ 1189 million in 2024 and is forecast to a readjusted size of US$ 1611 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 154
USD 3950.00 (Single User License)Global Home Use Lancets Market Insights, Forecast to 2031
The global Home Use Lancets market is projected to grow from US$ 1237 million in 2025 to US$ 1611 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
Published: 2025-04-13
Pages: 199
USD 4900.00 (Single User License)Global Home Use Lancets Market Research Report 2025
The global market for Home Use Lancets was valued at US$ 1189 million in the year 2024 and is projected to reach a revised size of US$ 1611 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published: 2025-04-13
Pages: 114
USD 2900.00 (Single User License)Global Home Use Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Home Use Lancets market size was US$ 1189 million in 2024 and is forecast to a readjusted size of US$ 1611 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 119
USD 4250.00 (Single User License)Home Use Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Home Use Lancets was estimated to be worth US$ 1189 million in 2024 and is forecast to a readjusted size of US$ 1611 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-02-19
Pages: 167
USD 3950.00 (Single User License)Global and Japan Home Use Lancets Market Report & Forecast 2024-2030
Home use lancets are small, sharp devices specifically designed for personal use at home to obtain a blood sample for various health tests, such as blood glucose monitoring. These lancets are often used with a lancing device that controls the depth of the puncture to minimize discomfort. Home use lancets are typically disposable, sterile, and easy to handle, allowing individuals to manage their health conveniently and safely in a non-clinical setting.
Published: 2024-10-23
Pages: 171
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now